Denis Katz MD

Criou um novo artigo

3 C

Precision Neurology 2026 From Syndromes to Signatures: The Strategic Rewiring of CNS Drug Development | #denis Katz medical affairs

Precision Neurology 2026 From Syndromes to Signatures: The Strategic Rewiring of CNS Drug Development

From syndromes to signatures: how precision biomarkers and regulatory strategy are rewiring CNS drug development and reducing late-stage failure.

Curtir

Comentario

Mudou sua imagem de perfil

3 C

Curtir

Comentario

Carregar mais posts

Homem
Postagens 2

08/21/90
Morando em United States
Localização United States
https://salienceclinical.com/

Sobre

AAV-mediated delivery of enzymes, neurotransmitter-modulating proteins, or neurotrophic factors has been extensively explored in Parkinson’s disease. While early studies suggested biological activity, several randomized controlled trials failed to meet primary clinical endpoints, highlighting the challenges of placebo effects, target engagement, and disease heterogeneity.

álbuns

(0)

Amigos

(0)

Curtiu

(0)

Grupos

(0)

3 C

Precision Neurology 2026 From Syndromes to Signatures: The Strategic Rewiring of CNS Drug Development

3 C

Linguagem